Cite
HARVARD Citation
Braulke, F. et al. (2022). First-line Treatment With Bendamustine and Rituximab for Old and Frail Patients With Aggressive Lymphoma: Results of the B-R-ENDA Trial. HemaSphere. 6 (12), pp. e808-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Braulke, F. et al. (2022). First-line Treatment With Bendamustine and Rituximab for Old and Frail Patients With Aggressive Lymphoma: Results of the B-R-ENDA Trial. HemaSphere. 6 (12), pp. e808-. [Online].